FTC's Gilman to Give Talk on Scope of Practice
As state legislatures continue to reassess restrictions on the scope of practice of Advanced Practice Registered Nurses (APRNs), Daniel Gilman of the Federal Trade Commission (FTC) will give us his perspectives on how nursing regulations affect competition at the LDI Health Policy seminar on Friday, December 8, 2017 at noon.
Dr. Gilman, an Attorney Advisor with the FTC’s Office of Policy Planning, has done extensive research and advocacy about the antitrust implications of health provider regulation. In 2014, he and LDI Senior Fellow Julie Fairman wrote an important paper on the impact of licensure—as well as competition policy—on consumer welfare. They explain:
For the health care professions, licensure and scope of practice regulations are two sides of the same coin: licensure restricts entry (or ongoing participation) in a given profession, and scope-of-practice restrictions help describe the metes-and-bounds of licensure – what a given professional license permits a person to do and, often prohibits others from doing. In that regard, general competition considerations for licensure may provide a useful baseline when considering potential costs and benefits of particular scope of practice restrictions.
The debate on APRNs’ scope of practice reflects broader issues of “who can provide what care?” and “who regulates whom?” We look forward to Dr. Gilman’s insights and the robust conversation it will no doubt spark.
Dan Gilman’s seminar, "Health Care Competition and Nursing Regulations - Who Regulates Whom, and to What Effect?" will be held on Friday, December 8, from 12pm to 1:20pm in the Colonial Penn Center Auditorium. To register, visit this page.